Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy
October 20, 2020
October 20, 2020
October 14, 2020
October 6, 2020
September 29, 2020
September 2, 2020
August 11, 2020
August 5, 2020
August 4, 2020
July 10, 2020
June 23, 2020